(Q40904252)

24 September 2017

Dapagliflozin lowers blood pressure in hypertensive and non-hypertensive patients with type 2 diabetes (English)

1 reference

24 September 2017

0 references

C David Sjöström

1

1 reference

24 September 2017

Peter Johansson

2

1 reference

24 September 2017

Agata Ptaszynska

3

1 reference

24 September 2017

James List

4

1 reference

24 September 2017

Eva Johnsson

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

25 May 2015

1 reference

Diabetes and Vascular Disease Research

24 September 2017

1 reference

24 September 2017

12

1 reference

24 September 2017

5

1 reference

24 September 2017

352-358

1 reference

Diabetes, hypertension, and cardiovascular disease: an update

24 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

The impact of history of hypertension and type 2 diabetes at baseline on the incidence of stroke and stroke mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Changes in skeletal muscle vascular resistance with weight gain: associations with insulin and sympathetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Renin-Angiotensin-aldosterone system in diabetes and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

The renin angiotensin aldosterone system in hypertension: roles of insulin resistance and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Sodium-retaining effect of insulin in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Standards of medical care in diabetes--2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Sodium-glucose cotransport inhibition with dapagliflozin in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: a randomized, double-blind, placebo-controlled, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Dapagliflozin added to glimepiride in patients with type 2 diabetes mellitus sustains glycemic control and weight loss over 48 weeks: a randomized, double-blind, parallel-group, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

Risk Factors for Stroke in Type 2 Diabetes Mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1479164115585298

21 January 2018

Identifiers

DOI

10.1177/1479164115585298

1 reference

24 September 2017

1 reference